Sanofi Target Raised to EUR125 From EUR100 by Intron Health
Sanofi Raised to Buy From Hold by Intron Health
Duvakitug, co-developed by Sanofi (SNY.US) and Teva (TEVA.US), is expected to enter phase 3 clinical trials in the second half of the year.
Sanofi (SNY.US) and Teva (TEVA.US) recently announced the detailed results obtained from their jointly developed monoclonal antibody duvakitug in the phase 2 clinical trial RELIEVE UCCD.
Sanofi Obtains Regulatory Approval for Blood Cancer Drug Sarclisa in Japan
Press Release: Sarclisa Approved in Japan for Patients With Newly Diagnosed Multiple Myeloma
Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency -- Barrons.com
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
Sanofi and Teva Report New Outcomes From Phase IIb Trial of Duvakitug
The Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis
Sanofi, Teva Pharmaceuticals Inflammatory Bowel Diseases' Drug Trial Shows Positive Results
Notable Healthcare Headlines for the Week: UnitedHealth, Moderna, Sanofi in Focus
Sanofi (SNY): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
Express News | Teva and Sanofi Present New Positive Phase 2B Study Results at Ecco 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-Tl1a) in Ulcerative Colitis and Crohn’s Disease
Sanofi Consumer Healthcare India's Net Profit Declines in Fiscal Q3
First Meeting of CDC Vaccine Advisory Panel Under RFK Jr. Postponed
Sanofi's Dupixent Achieves FDA Priority Review for Bullous Pemphigoid Treatment
Sanofi Treatment of Autoimmune Hemolytic Anemia Granted Orphan Status
Sanofi (SNYNF) Receives a Buy From Bernstein
U.S. stock market close: all three major indexes rose, with the S&P reaching a new high, and Microsoft launched quantum computing chips.
① Most US stocks related to Quantum Computing increased; ② Apple released the iPhone 16 at a starting price of 599 dollars; ③ Google Gemini may add AI video generation features; ④ Trump comments on Tesla possibly building a factory in India: it can happen, but it is unfair to the USA.
Sanofi Moves Closer to Selling Controlling Stake in $17bn-valued Opella